2013 Psychopharmacology Update Institute: The Impact of <i>DSM-5</i> on Child and Adolescent Psychopharmacological Treatments (Day 1)

Friday, January 25, 2013: 7:30 AM-6:00 PM

7:30 AM

Registration and Breakfast

8:30 AM

Welcoming Remarks

8:45 AM

Beyond Elementary: Advanced Approaches to the Treatment of ADHD Under DSM-5
Adelaide Robb, M.D. Children's National Medical Center, Washington, DC

10:00 AM

Break

10:15 AM

Advanced Treatment Strategies for Early Onset Psychosis with a DSM-5 Twist
Jean A. Frazier, M.D. UMASS Medical School, Worcester, MA

11:30 AM

Panel Discussion

12:00 PM

Lunch (on your own)

1:30 PM

The Impact of DSM-5 on Treatment of Posttraumatic Stress Disorder in Children and Adolescents
Michael S. Scheeringa, M.D., M.P.H. Tulane University, New Orleans, LA

2:45 PM

Break

3:00 PM

Treatment of Anxiety: A Modern Neuroscience Perspective
Daniel Pine, M.D. National Institute of Mental Health, Bethesda, MD

4:15 PM

Panel Discussion

4:45 PM

Reception

See more of: General Sessions